Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.067 CHF | -4.29% | -3.53% | +42.61% |
May. 08 | Addex to Present at BioEURquity Europe 2024 | DJ |
Apr. 30 | European Equities Traded in the US as American Depositary Receipts Decline | MT |
Sales 2024 * | - | Sales 2025 * | 20M 21.84M | Capitalization | 8.98M 9.81M |
---|---|---|---|---|---|
Net income 2024 * | -6M -6.55M | Net income 2025 * | 13M 14.2M | EV / Sales 2024 * | - |
Net cash position 2024 * | 362K 396K | Net cash position 2025 * | 7.23M 7.89M | EV / Sales 2025 * | 0.09 x |
P/E ratio 2024 * |
-0.78
x | P/E ratio 2025 * |
0.33
x | Employees | 23 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 48.13% |
Latest transcript on Addex Therapeutics Ltd
1 day | -4.29% | ||
1 week | -3.53% | ||
Current month | +7.54% | ||
1 month | -46.67% | ||
3 months | -4.65% | ||
6 months | +43.86% | ||
Current year | +42.61% |
Managers | Title | Age | Since |
---|---|---|---|
Tim Dyer
FOU | Founder | 56 | 01-12-31 |
Lénaic Teyssédou
DFI | Director of Finance/CFO | 38 | 17-05-31 |
Vincent Lawton
CHM | Chairman | 75 | 09-04-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jake Nunn
BRD | Director/Board Member | 53 | 18-05-31 |
Tim Dyer
FOU | Founder | 56 | 01-12-31 |
Vincent Lawton
CHM | Chairman | 75 | 09-04-15 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 0.0656 | -6.29% | 2 000 |
24-05-23 | 0.07 | +2.94% | 164,846 |
24-05-22 | 0.068 | +4.62% | 135,056 |
24-05-21 | 0.065 | -4.41% | 213,260 |
24-05-17 | 0.068 | +5.59% | 76,406 |
Delayed Quote Swiss Exchange, May 24, 2024 at 03:01 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.61% | 9.82M | |
+64.92% | 62.86B | |
-1.85% | 41.38B | |
+46.11% | 40.38B | |
-8.93% | 27.64B | |
+13.05% | 26.46B | |
-21.96% | 18.9B | |
+4.21% | 12.67B | |
+25.74% | 12.27B | |
+27.42% | 12.07B |
- Stock Market
- Equities
- ADXN Stock